INTRODUCTION {#sec1-1}
============

Ependymomas, although representing only 4--6% of all primary central nervous system tumors, are the most common tumors of glial origin found in the spinal cord.\[[@ref16]\] They account for 60% of all intramedullary tumors\[[@ref1][@ref11]\] with 50% of them arising from the filum terminale.\[[@ref6][@ref22]\] There, however, have been only 18 reported cases of primary spinal ependymomas\[[@ref2][@ref4]--[@ref10][@ref12]--[@ref15][@ref18]--[@ref21][@ref23][@ref24]\] located intradural and extramedullary, with one of these cases having an additional extradural component.\[[@ref7]\] The aim of this report is to present the second case of an intradural, extramedullary primary spinal ependymoma with an extradural component, but the first case with its initial presentation as an anaplastic ependymoma.

CASE REPORT {#sec1-2}
===========

A 50-year-old male who had no significant past medical history was noted to have progressive weakness of his lower extremities over a 2-week period. He had numbness starting in his mid-abdominal area and radiating down both legs to the top of both feet. He had no lower back or thoracic pain and no urinary or bowel incontinence. There was normal strength in the upper and lower extremities with no difficulty walking on heels and toes; however, he had difficulty in standing from a squat position. Sensory examination revealed decreased pin-prick and temperature sensation from just below the umbilicus down into the feet. There were normal deep tendon reflexes for his upper and lower extremities except for hyper-reflexia of the right knee. He also had bilaterally down-going toes with no clonus.

Magnetic resonance imaging (MRI) of the thoracic spine revealed a well-circumscribed isotense T1/bright T2 homogeneously enhancing intradural, extramedullary mass centered at the T5--6 level eccentric to the right \[Figure [1a](#F1){ref-type="fig"} and [b](#F1){ref-type="fig"}\]. A dural tail appeared posteriorly with the displacement of the cord to the left, with approximately 80% canal compromise. A portion of this mass in the form of a dumbbell shape extended through the right T5--6 neural foramen \[[Figure 1b](#F1){ref-type="fig"}\], which was otherwise normal in dimension. MRI of the brain, cervical, and lumbar spine was normal.

![(a) Sagittal and (b) axial T1-weighted MR images with the contrast of thoracic spine showing an intradural, extramedullary enhancing mass at T5--T6](SNI-2-119-g001){#F1}

The patient underwent laminectomy at T4--T6. An extradural component of the tumor was seen on the right T5--6 foramen \[[Figure 2a](#F2){ref-type="fig"}\]. Opening the dura showed an intradural and extramedullary mass with a clearly identifiable cleavage caudal and cephalad of the tumor without attachment to the dura \[[Figure 2b](#F2){ref-type="fig"}\]. The tumor was easily removed off the spinal cord except for the central portion that was attached to the pia and vasculature of the spinal cord, but did not invade the spinal cord. By microdissection, the entire tumor was removed. The tumor extended through the right T5--6 foramen and was easily dissected off the nerve root.

![(a) Intraoperative view of the extradural component of the tumor and (b) view of the intradural tumor](SNI-2-119-g002){#F2}

Sections of the tumor microscopically showed a moderately cellular ependymoma characterized by perivascular pseudorosette formation evidenced by round to irregular nuclei with fibrillar processes extending to and surrounding a central blood vessel. Mild nuclear pleomorphism with a mitotic activity was identified. Focal endothelial proliferation and a few foci of necrosis were seen. Several areas of the ependymoma displayed tanycytic features in which the cells were arranged in fascicles of variable density.

Immunohistochemical analysis showed a strong diffuse immunoreactivity for glial fibrillary acidic protein (GFAP), strong membrane immunoreactivity for CD56, and strong nuclear and cytoplasmic immunoreactivity for S100. The perinuclear dot-like immunoreactivity for the epithelial membrane antigen (EMA) was equivocal as the patchy staining noted was not of a greater intensity as that seen on the negative control study. The neoplastic cells were nonreactive for CD34 and neurofilament. The Ki-67 labeling index was variable with foci of the greatest labeling estimated at 5--15%. The final pathologic diagnosis was an anaplastic ependymoma, WHO grade 3.

Following surgery, the patient received external beam radiation between T3 and T8 with a total dose of 5000 cGy delivered using a three-field arrangement with daily doses of 200 cGy. The patient with 6-month follow-up had no recurrent tumor with normal MRI of the brain, cervical, and lumbar spine. He was neurologically intact except for poor proprioception in lower extremities which was unchanged from the time before initiation of surgery.

DISCUSSION {#sec1-3}
==========

A review of the 18 reported cases of primary intradural, extramedullary ependymomas of the spinal cord \[[Table 1](#T1){ref-type="table"}\] shows ages ranging from 24 to 69 years with a female predominance. Earlier case reports (1951--2005) had shown the tumors occurring predominantly in women\[[@ref5]--[@ref10][@ref13][@ref18]--[@ref21][@ref23][@ref24]\] with only one male\[[@ref15]\] reported. A hormonal theory was proposed by Duffau *et al*.\[[@ref8]\] in 2000 but was not confirmed by any cytogenic or molecular study and now with four recent cases\[[@ref2][@ref4][@ref12][@ref14]\] as well our case report identifying at total of six male patients, we believe that theory cannot be substantiated.

###### 

Reported cases of primary spinal intradural, extramedullary ependymomas

![](SNI-2-119-g003)

The location of the tumor often determines the clinical presentation. Mild to severe limb weakness, urinary disturbance and gait abnormalities mainly due to posterior column compression have been common clinical presentations. In almost all cases, these symptoms were reversed after surgery. The thoracic spine has been the most common location with five cases occurring in the cervical spine\[[@ref2][@ref12]--[@ref14][@ref21]\] and three cases in the lumbar spine.\[[@ref12][@ref15][@ref21]\] There were two cases\[[@ref12][@ref21]\] in which tumors occurred at multiple spinal levels on initial presentation \[[Table 1](#T1){ref-type="table"}\].

MRI imaging shows well-delineated intradural, extramedullary masses that homogeneously enhanced after gadolinium administration. One exception was the case of Graça *et al*.\[[@ref10]\] in which the lesion appeared hyperintense on T2-weighted and isointense on T1-weighted images without any enhancement and with an appearance typical of an arachnoid cyst. In general, intradural, extramedullary ependymomas are often mistaken for meningiomas or nerve sheath tumors and this has been further strengthened when there is an extradural component as seen in the case by De Bonis *et al*.,\[[@ref7]\] in which a dumbbell-shaped tumor extended in the left paravertebral space through the vertebral foramen. Our case was the second such case in which an extradural component was seen \[[Figure 2a](#F2){ref-type="fig"}\].

Intraoperative findings of these tumors have shown well-circumscribed encapsulated tumors with no dural attachment which can be easily removed from the surface of the spinal cord. We have found five exceptions.\[[@ref5][@ref10][@ref12][@ref14][@ref20]\] Cheng *et al*.\[[@ref5]\] and Krisman *et al*.\[[@ref14]\] both described a thin stalk between the tumor and the spinal cord that was easily amputated. Graça *et al*.\[[@ref10]\] and Iunes *et al*.\[[@ref12]\] both described the tumor infiltrating the arachnoid membrane requiring sharp dissection at the tumor--spinal cord interface. Robles *et al*.\[[@ref20]\] described a highly vascular lesion with infiltration into the pia requiring microvascular dissection. This was similar to our case. Both cases were Grade 3 indicating greater infiltration into the pia. In all these cases, there was no evidence of invasion into the cord intraoperatively or on MRI imaging and hence were all considered extramedullary.

[Table 1](#T1){ref-type="table"} lists the actual description of the pathology of these tumors as they appear in these 18 papers. Almost all tumors were benign on initial presentation except for five\[[@ref4][@ref13][@ref14][@ref18][@ref21]\] which were described as anaplastic or Grade 3. Our case was also an anaplastic ependymoma on initial presentation. Recurrence at the same level occurred in two cases,\[[@ref2][@ref4]\] and at a different level in one case.\[[@ref20]\] All recurrent tumors were anaplastic. Two patients had cerebral metastasis from their spinal tumors.\[[@ref2][@ref21]\]

Treatment for the 18 cases varied and depended on the pathology seen on initial presentation or recurrence. Benign tumors were treated with complete surgical resections with no adjunctive treatment. This was similar to the treatment of benign intramedullary cord ependymomas reported by Brotchi *et al*.\[[@ref3]\] who recommended gross total resection without adjunctive radiation therapy. For the five cases\[[@ref4][@ref13][@ref14][@ref18][@ref21]\] of anaplastic ependymomas on initial presentation, the treatment varied. Katoh *et al*.\[[@ref13]\] and Oliver *et al*.\[[@ref18]\] did not give any radiation treatment postsurgery and had favorable outcomes but the follow-up period was short, 3--6 months. Schuurmans *et al*.\[[@ref21]\] radiated the entire spinal cord with 20 sessions of 1.8 G with a boost to the cervical and lumbar levels, where the tumor occurred. Similarly, Cease *et al*.\[[@ref4]\] advised his patient to have radiotherapy after the T5 anaplastic ependymoma was completely resected, but the patient refused. One year later with recurrence of the tumor, the patient had complete resection of the tumor with whole central nervous system radiotherapy. The patient died 1 month after treatment. Krisman *et al*.\[[@ref14]\] treated his case with complete resection with adjunctive radiotherapy. The treatment in our case was complete resection of the tumor with neurospinal radiotherapy to T3--T8.

The hypothesis for the formation of these intradural, extrameduallary ependymomas is that the heterotopic glial tissue is left in the intradural space as the neural tube closes.\[[@ref6][@ref8][@ref17][@ref19]\] This most likely occurs at one region in the spinal cord. Schuurmans *et al*.\[[@ref21]\] hypothesized in their case that although cervical and lumbar tumors were found on initial presentation, one of the tumors must have been the primary tumor. They believed that the lumbar was most likely the primary ependymoma and it migrated via the cerebrospinal fluid (CSF) circulation to the cervical spine. This was even made more pausable when 2 years after the initial presentation the patient had a seizure and was found to have a large right temporal anaplastic ependymoma that was located in the sylvian fissure without any intracranial attachment. We believe that the process may be a combination of both and that the primary tumor most likely was ectopic and benign initially. If it was not detected early it may be transformed to a more malignant type and found as initial presentation.\[[@ref4][@ref13][@ref14][@ref18][@ref21]\] Once surgery has occurred, the CSF is seeded and the recurrence can occur at another spinal level\[[@ref20]\] or in the brain.\[[@ref2][@ref21]\] Of note, all the recurrences were found in a more advanced stage.\[[@ref2][@ref20]\]

CONCLUSIONS {#sec1-4}
===========

Primary spinal intradural, extramedullary ependymomas are very rare with only 18 reported cases. This tumor can be confused with meningiomas and nerve sheath tumors due to its similarity in MRI findings. Our case report is the first intradural, extramedullary ependymoma that is anaplastic and has an extradural component. The review of the literature provides little information on the treatment and prognosis for these tumors especially if they are anaplastic. We propose that the treatment, as done in our case, should be complete resection of the tumor with spinal radiotherapy to the tumor level.
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